Cargando…

Delivery of gene silencing agents for breast cancer therapy

The discovery of RNA interference has opened the door for the development of a new class of cancer therapeutics. Small inhibitory RNA oligos are being designed to specifically suppress expression of proteins that are traditionally considered nondruggable, and microRNAs are being evaluated to exert b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Haifa, Mittal, Vivek, Ferrari, Mauro, Chang, Jenny
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3706796/ https://www.ncbi.nlm.nih.gov/pubmed/23659575 http://dx.doi.org/10.1186/bcr3413

Ejemplares similares

Gold Nanoparticle Approach to the Selective Delivery of Gene Silencing in Cancer—The Case for Combined Delivery?
por: Mendes, Rita, et al.
Publicado: (2017)

Nano and Microtechnologies for the Delivery of Oligonucleotides with Gene Silencing Properties
por: Rosa, Giuseppe De, et al.
Publicado: (2009)

Nanocarriers for delivery of siRNA as gene silencing mediator
por: Morales-Becerril, Aideé, et al.
Publicado: (2022)

Selective gene silencing by viral delivery of short hairpin RNA
por: Sliva, Katja, et al.
Publicado: (2010)

Boron delivery agents for neutron capture therapy of cancer
por: Barth, Rolf F., et al.
Publicado: (2018)

Antisense Gene Silencing: Therapy for Neurodegenerative Disorders?
por: Nielsen, Troels T., et al.
Publicado: (2013)

Variables and Strategies in Development of Therapeutic Post-Transcriptional Gene Silencing Agents
por: Sullivan, Jack M., et al.
Publicado: (2011)

Dendrimers as Carriers for siRNA Delivery and Gene Silencing: A Review
por: Wu, Jiangyu, et al.
Publicado: (2013)

Aptamer-Functionalized Nanoparticles Mediate PD-L1 siRNA Delivery for Effective Gene Silencing in Triple-Negative Breast Cancer Cells
por: Camorani, Simona, et al.
Publicado: (2022)

Multi-Functional Boron-Delivery Agents for Boron Neutron Capture Therapy of Cancers
por: Oloo, Sebastian O., et al.
Publicado: (2023)

Nanoparticle-Mediated Therapeutic Agent Delivery for Treating Metastatic Breast Cancer—Challenges and Opportunities
por: Li, Yunfei, et al.
Publicado: (2018)

Electroactive nanoinjection platform for intracellular delivery and gene silencing
por: Shokouhi, Ali-Reza, et al.
Publicado: (2023)

siRNA Versus miRNA as Therapeutics for Gene Silencing
por: Lam, Jenny K W, et al.
Publicado: (2015)

TRUE Gene Silencing
por: Nashimoto, Masayuki
Publicado: (2022)

Nanocarrier-mediated co-delivery of chemotherapeutic drugs and gene agents for cancer treatment
por: Kang, Lin, et al.
Publicado: (2015)

Formulation Development for Transdermal Delivery of Raloxifene, a Chemoprophylactic Agent against Breast Cancer
por: Vora, Deepal, et al.
Publicado: (2022)

Epithelial-mesenchymal transition, cancer stem cells and treatment resistance
por: Dave, Bhuvanesh, et al.
Publicado: (2012)

Targeted Gene Delivery Therapies for Cervical Cancer
por: Áyen, Ángela, et al.
Publicado: (2020)

DNAzyme as a rising gene-silencing agent in theranostic settings
por: Zhang, Nan
Publicado: (2022)

Mesoporous silica-based nanoplatforms for the delivery of photodynamic therapy agents
por: Hong, Suk ho, et al.
Publicado: (2017)

Molecular targeting of FATP4 transporter for oral delivery of therapeutic peptide
por: Hu, Zhenhua, et al.
Publicado: (2020)

Nanoparticle Delivery of Immunostimulatory Agents for Cancer Immunotherapy
por: Zhuang, Jia, et al.
Publicado: (2019)

Targeted Drug Delivery Systems for Curcumin in Breast Cancer Therapy
por: Huang, Mian, et al.
Publicado: (2023)

Targeted Delivery of Drugs and Genes Using Polymer Nanocarriers for Cancer Therapy
por: Xia, Wentao, et al.
Publicado: (2021)

Monitoring the progression of metastatic breast cancer on nanoporous silica chips
por: Fan, Jia, et al.
Publicado: (2012)

Multi-Functionalized Heteroduplex Antisense Oligonucleotides for Targeted Intracellular Delivery and Gene Silencing in HeLa Cells
por: Sousa de Almeida, Mauro, et al.
Publicado: (2022)

Quantum dots to monitor RNAi delivery and improve gene silencing
por: Chen, Alice A., et al.
Publicado: (2005)

Efficient gene delivery and silencing of mouse and human pancreatic islets
por: Lefebvre, Bruno, et al.
Publicado: (2010)

Reversing multidrug resistance in breast cancer cells by silencing ABC transporter genes with nanoparticle-facilitated delivery of target siRNAs
por: Li, Yong Tsuey, et al.
Publicado: (2012)

Nickel and Epigenetic Gene Silencing
por: Sun, Hong, et al.
Publicado: (2013)

Virus-Induced Gene Silencing, a Post Transcriptional Gene Silencing Method
por: Unver, Turgay, et al.
Publicado: (2009)

Adenovirus receptors and their implications in gene delivery
por: Sharma, Anurag, et al.
Publicado: (2009)

The Potential of Mesenchymal Stromal Cells in Neuroblastoma Therapy for Delivery of Anti-Cancer Agents and Hematopoietic Recovery
por: Hochheuser, Caroline, et al.
Publicado: (2021)

Nail Changes With Chemotherapeutic Agents and Targeted Therapies
por: Mittal, Shankila, et al.
Publicado: (2022)

Stimuli-Responsive Gene Delivery Nanocarriers for Cancer Therapy
por: Zhang, Qingfei, et al.
Publicado: (2023)

Monoclonal Antibodies, Gene Silencing and Gene Editing (CRISPR) Therapies for the Treatment of Hyperlipidemia—The Future Is Here
por: Hermel, Melody, et al.
Publicado: (2023)

Lipid-Based Nanomaterials for Drug Delivery Systems in Breast Cancer Therapy
por: Rethi, Lekshmi, et al.
Publicado: (2022)

Nano drug delivery systems improve metastatic breast cancer therapy
por: Zhu, Runqi, et al.
Publicado: (2021)

Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancer
por: Birgisdottir, Valgerdur, et al.
Publicado: (2006)

Aptamer-functionalized Hybrid Nanoparticles to Enhance the Delivery of Doxorubicin into Breast Cancer Cells by Silencing P-glycoprotein
por: Chandra, Sruti, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_u8qp66gkm81usou5vkjm94f5et